BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jia Y, Deng H, Qin Q, Ma Z. JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes. Neuroscience Letters 2020;720:134779. [DOI: 10.1016/j.neulet.2020.134779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Li C, Xie J. Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease. Neurosci Bull 2021;37:275-7. [PMID: 32964366 DOI: 10.1007/s12264-020-00585-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tortora C, Di Paola A, Creoli M, Argenziano M, Martinelli M, Miele E, Rossi F, Strisciuglio C. Effects of CB2 and TRPV1 Stimulation on Osteoclast Overactivity Induced by Iron in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2022:izac073. [PMID: 35472140 DOI: 10.1093/ibd/izac073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Morcuende A, García-gutiérrez MS, Tambaro S, Nieto E, Manzanares J, Femenia T. Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders. Front Psychiatry 2022;13:866052. [DOI: 10.3389/fpsyt.2022.866052] [Reference Citation Analysis]
4 Hashiesh HM, Sharma C, Goyal SN, Jha NK, Ojha S. Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Front Pharmacol 2021;12:702675. [PMID: 34393784 DOI: 10.3389/fphar.2021.702675] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Egaña-Huguet J, Soria-Gómez E, Grandes P. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. Int J Mol Sci 2021;22:13231. [PMID: 34948035 DOI: 10.3390/ijms222413231] [Reference Citation Analysis]
6 Hashiesh HM, Jha NK, Sharma C, Gupta PK, Jha SK, Patil CR, Goyal SN, Ojha SK. Pharmacological potential of JWH133, a cannabinoid type 2 receptor agonist in neurodegenerative, neurodevelopmental and neuropsychiatric diseases. Eur J Pharmacol 2021;909:174398. [PMID: 34332924 DOI: 10.1016/j.ejphar.2021.174398] [Reference Citation Analysis]
7 Vicente-Acosta A, Ceprian M, Sobrino P, Pazos MR, Loría F. Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection. Front Pharmacol 2022;13:888222. [PMID: 35721207 DOI: 10.3389/fphar.2022.888222] [Reference Citation Analysis]